AZN Multiplikator Forward P/S AstraZeneca AB

Patent risks and regulatory price controls are weighing on the stability of AstraZeneca PLC (AZN). The forward P/S valuation reflects the dynamics of these factors, smoothing out market noise. Efficiency is being enhanced through outsourced manufacturing and logistics, as well as the active acquisition of biotech startups to refresh the portfolio. The value of 2.90 serves as the final mark for this indicator's level.

AZN AstraZeneca Plc: Rasio kapitalisasi marang dodolan sing dikarepake ing interval 04.07.2022 - 13.11.2026

Rincian metrik komprehensif lan analitis AstraZeneca Corp. (AZN)

- rega saiki lan proyeksi nilai saham:

Rega saham AstraZeneca|AZN - Rentang target analis

- data kapitalisasi pasar:

Kapitalisasi pasar AstraZeneca Corp.|AZN - Nilai Perusahaan

- statistik nilai buku emiten:

Aset Bersih saben Siji Saham AstraZeneca|AZN - Pambiji Buku Bisnis|Rasio Kapitalisasi marang Aset Bersih astrazeneca.com|AZN - Aset Agregat Bisnis

- indikator beban kredit lan likuiditas emiten:

- data bathi bisnis lan rasio investasi:

AZN - Bathi perusahaan|Proyeksi bathi mangsa ngarep AstraZeneca PLC|AZN - Kapitalisasi marang bathi|Pangali Forward P/E AstraZeneca AB|AZN - Pangali rega marang bathi tumrap wutah|Pangali EV/EBITDA AstraZeneca Corp.|AZN - Bathi operasional EBITDA|Bathi resik saben saham sajrone 12 wulan pungkasan AstraZeneca|AZN - Bathi saben saham sajroning taun lumaku|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan astrazeneca.com|AZN - Dinamika bathi saben saham ing taun lumaku|Prakiraan wutah bathi resik saben saham kanggo taun ngarep AstraZeneca PLC

- indikator volume dodolan lan pendapatan:

AZN - Pendapatan perusahaan|Prakiraan volume dodolan AstraZeneca|AZN - Kapitalisasi marang pendapatan|Multiplikator Forward P/S AstraZeneca Corp.

Analisis fundamental perusahaan:AstraZeneca (AZN)

Forward P/S measures an asset's market value relative to projected revenue, allowing for the determination of the premium paid for future business growth. The dynamics of this multiple help investors assess the stability of the control premium during periods of volatility. By analyzing the forward price-to-sales valuation, one can observe how geopolitical barriers and component logistics disruptions at AstraZeneca PLC (AZN) impact expectations for future sales.

Pesaing langsung

Multiplikator Forward P/S LLY (Eli Lilly)|Prakiraan rega marang pendapatan AbbVie Inc|Novartis Inc. - Multiplikator Forward P/S|MRK - Multiplikator Forward P/S|Novo Nordisk A/S (NVO) - Rasio rega marang prakiraan pendapatan|AMGN - Rasio kapitalisasi marang dodolan sing dikarepake|Multiplikator forward rega marang pendapatan PFE|SNY (Sanofi SA) - Rasio rega marang pendapatan sing dikarepake|Rasio rega marang prakiraan pendapatan BMS (BMY)|GSK (gsk.com) - Rega forward marang dodolan|Multiplikator Forward P/S TAK (Takeda Pharmaceutical)|Multiplikator Forward P/S tevapharm.com TEVA|RDY: Multiplikator forward rega marang pendapatan|Rega mangsa ngarep marang pendapatan VTRS|ROIV: Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Zai Lab Corp (ZLAB)|Rasio rega marang prakiraan pendapatan Bausch Health Companies|Kapitalisasi marang prakiraan pendapatan COSM (cosmosholdingsinc.com)